A clinical pilot study reveals a new way to improve glycemic control by replacing daily breakfast and afternoon snacks with a diabetes-specific nutritional shake. 

The likelihood of developing type 2 diabetes can be detected at an early age. 

Patients taking the DPP-4 inhibitor sitagliptin had lower risk of needing intensive care or needing mechanical ventilation. 

Young children with type 1 diabetes often experience greater insulin variability, leading to more complications and a subpar quality of life.

The growing brain is more susceptible to adverse effects from glucose variability.

Earlier diagnosis and treatment prevent complications.

A recently published meta-analysis puts metformin to the test to see how well it lines up against other T2DM “Medication All-Star Team” members. 

The unique benefits of using empagliflozin need to be considered when determining treatments for type 2 patients.

Can the use of polypharmacy put patients at increased risk for hospitalization, falls, and all-cause mortality?  

A new phase 3 study on novel SGLT inhibitor shows favorable results in those living with severe renal impairment.